BTK Inhibitor Cardiac Side Effect Management for the Advanced Practice Provider

LOGIN TO WATCH

Presenters: Alexandra Lynch, PA-C, Dana-Farber Cancer Institute

BTK inhibitors have transformed the treatment landscape for CLL and SLL — improving outcomes, extending survival, and reshaping standards of care. But with those advancements come new challenges for clinicians, especially when it comes to managing cardiac side effects.

Learn how to take control of those challenges with Alexandra Lynch, PA-C (Dana-Farber Cancer Institute). She’ll go beyond the mechanism and into the “what now?” moments of patient care.

Learn how to:

• Spot hypertension before it escalates
• Manage bleeding in real time
• Make fast, informed decisions when arrhythmias appear

For additional information or login assistance, reach out to NCODA’s Jonathan Rivera.